Immune responses to the 105AD7 human anti-idiotypic vaccine after intensive chemotherapy, for osteosarcoma

105AD7 is a human monoclonal antibody that mimics the complement regulatory protein, CD55, overexpressed by many solid tumours including osteosarcoma. This study was designed to assess the toxicity and efficacy of this vaccine in a young age group of patients within 1–6 months of myleosuppressive ch...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Pritchard-Jones, K, Spendlove, I, Wilton, C, Whelan, J, Weeden, S, Lewis, I, Hale, J, Douglas, C, Pagonis, C, Campbell, B, Alvarez, P, Halbert, G, Durrant, L G
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2005
Teme:
Clinical Study
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361999/
https://ncbi.nlm.nih.gov/pubmed/15798769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602500
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki